![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 Rippe Lifestyle Institute, Shrewsbury, MA 01545 and Celebration Health Florida, Celebration, FL 34747; 4 Center for Lifestyle Medicine and Department of Health Professions, University of Central Florida, Orlando, FL 32816; and 5 Department of Nutrition and Food Sciences, University of Rhode Island, Kingston, RI 02881
Rates of overweight and obesity have been on a steady rise for decades, and the problems society faces from this and associated metabolic diseases are many. As a result, the need to understand the contributing factors is great. A very compelling case can be made that excess sugar consumption has played a significant role. In addition, fructose, as a component of the vast majority of caloric sweeteners, is seen to be particularly insidious. Evidence shows that fructose bypasses many of the body's satiating signals, thus potentially promoting overconsumption of energy, weight gain, and the development on insulin resistance. It has also been shown to increase uric acid levels, which in turn promotes many of the abnormalities seen in the metabolic syndrome including hypertriglyceridemia. However, the main source of fructose in the diet is high-fructose corn syrup (HFCS), an artificially manufactured disaccharide that is only 55% fructose. This review highlights the fact that limited data are available about the metabolic effects of HFCS compared with other caloric sweeteners. The data suggest that HFCS yields similar metabolic responses to other caloric sweeteners such as sucrose.
* To whom correspondence should be addressed. E-mail: tangelop{at}mail.ucf.edu.
Published online 29 April 2009.
This article has been cited by other articles:
|
|
 |
|
  J. S. White Comment on: New insights into the epidemiology of gout Rheumatology, November 11, 2009; (2009) kep349v1. [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Murphy The State of the Science on Dietary Sweeteners Containing Fructose: Summary and Issues to Be Resolved J. Nutr., June 1, 2009; 139(6): 1269S - 1270S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Livesey Fructose Ingestion: Dose-Dependent Responses in Health Research J. Nutr., June 1, 2009; 139(6): 1246S - 1252S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Jones Dietary Sweeteners Containing Fructose: Overview of a Workshop on the State of the Science J. Nutr., June 1, 2009; 139(6): 1210S - 1213S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. White Misconceptions about High-Fructose Corn Syrup: Is It Uniquely Responsible for Obesity, Reactive Dicarbonyl Compounds, and Advanced Glycation Endproducts? J. Nutr., June 1, 2009; 139(6): 1219S - 1227S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Moran Fructose and Satiety J. Nutr., June 1, 2009; 139(6): 1253S - 1256S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Bantle Dietary Fructose and Metabolic Syndrome and Diabetes J. Nutr., June 1, 2009; 139(6): 1263S - 1268S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Schaefer, J. A. Gleason, and M. L. Dansinger Dietary Fructose and Glucose Differentially Affect Lipid and Glucose Homeostasis J. Nutr., June 1, 2009; 139(6): 1257S - 1262S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Marriott, N. Cole, and E. Lee National Estimates of Dietary Fructose Intake Increased from 1977 to 2004 in the United States J. Nutr., June 1, 2009; 139(6): 1228S - 1235S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Stanhope and P. J. Havel Fructose Consumption: Considerations for Future Research on Its Effects on Adipose Distribution, Lipid Metabolism, and Insulin Sensitivity in Humans J. Nutr., June 1, 2009; 139(6): 1236S - 1241S. [Abstract] [Full Text] [PDF]
|
|
